
Sign up to save your podcasts
Or


In this special episode on Early Identification and Delay of Type 1 Diabetes, Dr. Neil Skolnik this emerging area with Dr. Jay Shubrook. This special episode is supported by an independent educational grant from Sanofi.
Presented by:
Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health
Jay Shubrook, D.O. - Professor and Director of Diabetes Services, Touro University. Past Chair, The American Diabetes Association Primary Care Advisory Group, Past Chair of the American College of Diabetology.
Selected References and Resources referred to the in the Podcast:
Webinar Registration (Apr 28, 2025 10:00 AM):
Early Detection Saves Lives: Implementing Type 1 Diabetes Screening in Pediatric and Primary Care
References:
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care 2024;47(8):1276–1298
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med 2019;381:603-613
Resources for Auto-antibody Testing:
Type 1 Diabetes TrialNet Centers of Excellence Locations
Type 1 Risk test
Trialnet
By American Diabetes Association4.5
9494 ratings
In this special episode on Early Identification and Delay of Type 1 Diabetes, Dr. Neil Skolnik this emerging area with Dr. Jay Shubrook. This special episode is supported by an independent educational grant from Sanofi.
Presented by:
Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health
Jay Shubrook, D.O. - Professor and Director of Diabetes Services, Touro University. Past Chair, The American Diabetes Association Primary Care Advisory Group, Past Chair of the American College of Diabetology.
Selected References and Resources referred to the in the Podcast:
Webinar Registration (Apr 28, 2025 10:00 AM):
Early Detection Saves Lives: Implementing Type 1 Diabetes Screening in Pediatric and Primary Care
References:
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care 2024;47(8):1276–1298
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med 2019;381:603-613
Resources for Auto-antibody Testing:
Type 1 Diabetes TrialNet Centers of Excellence Locations
Type 1 Risk test
Trialnet

135 Listeners

320 Listeners

696 Listeners

495 Listeners

291 Listeners

262 Listeners

3,331 Listeners

1,152 Listeners

196 Listeners

89 Listeners

363 Listeners

251 Listeners

369 Listeners

85 Listeners

13 Listeners